tenk.fyi

BIOCRYST PHARMACEUTICALS INC

BCRXNasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

$874.8M

94.1% YoY

Net Income

$263.9M

396.9% YoY

EPS

$1.21

381.4% YoY

Cash

$89.7M

14.3% YoY

FY 2025 · As of 2025-12-31